| TRS | testicular regression syndrome; total reducing sugars; tubuloreticular structure |
|---|---|
| ADP | adenopathy; adenosine diphosphate; administrative psychiatry; approved drug product; area diastolic ... |
| ADPR | adenosine diphosphate ribose |
| ADPRT | adenosine diphosphate ribosyltransferase |
| CAMP | Christie-Atkins-Munch-Petersen [test]; computer-assisted menu planning; concentration of adenosine m... |
| ADP | Adenosine 5'-diphosphate |
|---|---|
| ADPRT | Adenosine diphosphate ribosyl transferase |
| cADPR | Cyclic adenosine 5'-diphosphate ribose |
| ADP | Poly(adenosine diphosphate |
| CDP-choline | Cytidin-diphosphate-Choline |
| adenosine diphosphate sugars | Esters formed between the aldehydic carbon of sugars and the terminal phosphate of adenosine diphosphate. (12 Dec 1998) |
|---|
| guanosine diphosphate sugars | Esters formed between the aldehydic carbon of sugars and the terminal phosphate of guanosine diphosphate. (12 Dec 1998) |
|---|---|
| nucleoside-diphosphate sugars | Nucleoside diphosphates linked through the 5'-diphosphoric group with simple or complex carbohydrates; e.g., GDP-mannose, UDP-glucose (UDPG), dTDP-glucosamine. (05 Mar 2000) |
| adenosine 5'-diphosphate | A condensation product of adenosine with pyrophosphoric acid, formed from ATP by the hydrolysis of the terminal phosphate group of the latter compound. Acronym: ADP (05 Mar 2000) |
| adenosine diphosphate | <biochemistry> ADP is used as an adenine, a ribose and a diphosphate unit. (06 May 1997) |
| adenosine diphosphate glucose | <chemical> Serves as the glycosyl donor for formation of bacterial glycogen, amylose in green algae, and amylopectin in higher plants. Chemical name: Adenosine 5'-(trihydrogen diphosphate), P'-alpha-D-glucopyranosyl ester (12 Dec 1998) |
| adenosine diphosphate ribose | <chemical> Adenosine 5'-(trihydrogen diphosphate),5'-5-ester with d-ribose. An ester formed between the aldehydic carbon of ribose and the terminal phosphate of adenosine diphosphate. Serves as a ribose carrier. Chemical name: Adenosine 5'-(trihydrogen diphosphate), P'-5-ester with D-ribose (12 Dec 1998) |
| adenosine diphosphate ribose cyclase | <enzyme> Catalyses conversion of nadp to 2'-phospho-cyclic adenosine diphosphoribose; do not use for formation of cyclic adpribose (see ADP-ribosyl cyclase) Registry number: EC 4.6.- Synonym: 2'-p-adpr cyclase (26 Jun 1999) |
| poly adenosine diphosphate ribose | <chemical> A polynucleotide formed from NAD in the presence of NAD+ nucleosidase. Chemical name: Adenosine 5'-(trihydrogen diphosphate), P'-5-ester with D-ribose, homopolymer (12 Dec 1998) |
| amino sugars | Sugar's in which a hydroxyl group has been replaced with an amino group; e.g., d-glucosamine. (05 Mar 2000) |
| polyisoprenyl phosphate sugars | Compounds functioning as activated glycosyl carriers in the biosynthesis of glycoproteins and glycophospholipids. They include the polyisoprenyl pyrophosphates. (12 Dec 1998) |
| sugars | Those carbohydrates (saccharides) having the general composition (CH2O)n and simple derivatives thereof. Although the simple monomeric sugars (glycoses) are often written as polyhydroxy aldehydes or ketones, e.g., HOCH2-(CHOH)4-CHO for aldohexoses (e.g., glucose) or HOCH2-(CHOH)3-CO-CH2OH for 2-ketoses (e.g., fructose), cyclization can give rise to varied structures as described below. Sugars are generally identifiable by the ending -ose or, if in combination with a nonsugar (aglycon), -oside or -osyl. Sugars especially d-glucose, are the chief source of energy, by oxidation, in nature, and they and their derivatives (e.g., d-glucosamine, d-glucuronic acid), in polymeric form, are major constituents of mucoproteins, bacterial cell walls, and plant structural material (e.g., cellulose). Sugars are often found in combination with steroids (steroid glycosides) and other aglycons. (05 Mar 2000) |
| dTDP-sugars | Sugars or sugar derivatives bonded to dTDP. (05 Mar 2000) |
| adenosine | <biochemistry> A ribonucleotide which consists of the nitrogenous base adenine linked to the sugar ribose. <drug> A cardiac drug used in terminating PSVT involving reentry pathways that include the AV node or Wolff-Parkinson-White syndrome. For atrial flutter, atrial fibrillation, atrial or ventricular tachycardias, adenosine may produce transient AV block that may help identify the rhythm. Pharmacologic action: Endogenous purine nucleoside that depresses AV node and sinus node activity. Brief duration of action (1-2 min). Dose: Rapid 6 mg IV bolus over 1-3 sec. May repeat at 12 mg IV bolus within 1-2 min Patients taking theophylline may require larger doses. Use a smaller dose with cardiac transplant patients. Potential complications: Common but transient - flushing, dyspnea, chest pain, bradycardia, and ventricular ectopy. Theophylline (and caffeine) blocks adenosine's effects. Dipyridamole potentiates adenosine's effects. Use other agents to avoid these drug interactions. (15 Mar 2000) |
| adenosine 3',5'-cyclic monophosphate | An activator of phosphorylase kinase and an effector of other enzymes, formed in muscle from ATP by adenylate cyclase and broken down to 5'-AMP by a phosphodiesterase; sometimes referred to as the "second messenger." A related compound (2',3') is also known. Synonym: cyclic adenylic acid, cyclic AMP, cyclic phosphate. Acronym: cAMP (05 Mar 2000) |
| adenosine 3',5'-cyclic phosphate phosphodiesterase | <enzyme> An enzyme that catalyses the hydrolysis of adenosine 3',5'-cyclic phosphate forming 5'-AMP. A crucial step in the regulation of cellular adenosine 3',5'-cyclic phosphate levels. Inhibited by caffeine. Synonym: cAMP phosphodiesterase. (05 Mar 2000) |
Synonyms : Diphosphate Sugars, Adenosine, Sugars, ADP, Sugars, Adenosine Diphosphate
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|